Fig. 4.
![Fig. 4. Five-year overall survival. / Actuarial 5-year overall survival of patients grafted with low ([A] ≤ 2.4 × 108/kg; n = 247, 45%), intermediate ([B] > 2.4 × 108/kg and ≤ 5 × 108/kg; n = 452, 51%), and high cell dose ([C] > 5 × 108/kg; n = 206, 56%). Pvalues in the log-rank test are as follows: A versus B,P < .06; A versus C, P < .007; and B versus C, P = .2.](https://ash.silverchair-cdn.com/ash/content_public/journal/blood/100/12/10.1182_blood-2002-01-0339/5/h82323454004.jpeg?Expires=1735548283&Signature=kWL0uvBIye6iT-8t~JVuVW-mDpgmQNwESI7CGAF1FGWvsXFHlZAAEKOO1scbUcMFEL2KZAtOEnm4oylRbUgZEZNwnDaoFrZd63Q3LSg0YGTrGx1Flp1d2d9N3vStVFDbm8-a3py-2CflSy6AUriGZDPutawlULKah~QRF4CQ8DC3ovCx9E8SlVoeejwLV~RyFXOoEIOfrnXylQWy7TpHFz8rrnxSNx1K5LycM1TbJTA14350LSBbL39-6vFsr9fh6nMw~i98ehVr1vHJp4k0Xfs4WUhtgD~FEgc4xkCs7Sq4r0xACaLMb9jpotZOa4yaT9G~dHznewFl5U8xdiGBfQ__&Key-Pair-Id=APKAIE5G5CRDK6RD3PGA)
Five-year overall survival.
Actuarial 5-year overall survival of patients grafted with low ([A] ≤ 2.4 × 108/kg; n = 247, 45%), intermediate ([B] > 2.4 × 108/kg and ≤ 5 × 108/kg; n = 452, 51%), and high cell dose ([C] > 5 × 108/kg; n = 206, 56%). Pvalues in the log-rank test are as follows: A versus B,P < .06; A versus C, P < .007; and B versus C, P = .2.
